Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Painreform Ltd (PRFX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: PRFX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -55.23% | Avg. Invested days 17 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 4.22M USD | Price to earnings Ratio - | 1Y Target Price 12 |
Price to earnings Ratio - | 1Y Target Price 12 | ||
Volume (30-day avg) 70800 | Beta 0.61 | 52 Weeks Range 1.73 - 61.20 | Updated Date 04/1/2025 |
52 Weeks Range 1.73 - 61.20 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -147.36 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -195.07% | Return on Equity (TTM) -716.67% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -796680 | Price to Sales(TTM) - |
Enterprise Value -796680 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA -2.32 | Shares Outstanding 874862 | Shares Floating 144510 |
Shares Outstanding 874862 | Shares Floating 144510 | ||
Percent Insiders 0.79 | Percent Institutions 4.58 |
Analyst Ratings
Rating 3 | Target Price 12 | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Painreform Ltd
Company Overview
History and Background
There is no publicly traded US stock with the name Painreform Ltd. Therefore, I am unable to create a company profile.
Core Business Areas
Leadership and Structure
Since Painreform Ltd. is not a known public entity, I cannot provide information on its leadership and structure.
Top Products and Market Share
Key Offerings
Market Dynamics
Industry Overview
Without a specific company to analyze, I cannot provide an industry overview.
Positioning
Without information on Painreform Ltd, I cannot determine its market position.
Total Addressable Market (TAM)
Unable to provide the Total Addressable Market (TAM) due to the company not existing.
Upturn SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
Competitors and Market Share
Key Competitors
Competitive Landscape
Cannot evaluate the competitive landscape without a defined company.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: No historical growth data available.
Future Projections: No future projections available.
Recent Initiatives: No recent initiatives available.
Summary
Painreform Ltd. is not a publicly traded company in the US. Therefore, it is impossible to assess its market position, financial health, or competitive advantages. Comprehensive financial analysis and market assessment are impossible in the absence of available company data. Any analysis based on a non-existent company would be speculative and unreliable. Further information or clarification about the company is required.
Similar Companies
Sources and Disclaimers
Data Sources:
- N/A
Disclaimers:
Analysis is based on the assumption that Painreform Ltd. does not exist as a publicly traded entity. Data and analysis are limited by this fact.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Painreform Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2020-09-01 | Interim CEO & Executive Chairman Dr. Ehud Geller Ph.D. | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 7 | Website https://www.painreform.com |
Full time employees 7 | Website https://www.painreform.com | ||
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.